Canadian researchers have identified a gene mutation that appears to be common in a rare form of ovarian cancer known as granulosa-cell tumors. They discovered the mutation by sequencing RNA from the tumors of four women with the disease, which accounts for up to 5 percent of ovarian cancers. Read more > >
By Dr. Bradford Wood
The new Center for Interventional Oncology was established earlier this year at the NIH Clinical Center (CC) to develop and translate image-guided technologies for localized cancer treatments. The Center is a collaboration involving the CC, NCI, and the National Heart, Lung, and Blood Institute. The Center will draw on the strengths of each institute to investigate how imaging technology and advanced devices can diagnose and treat localized cancers in ways that are precisely targeted and minimally or non-invasive. It will also help bridge the gap between diagnosis and therapy, and between emerging technology and procedural medicine. Read more > >
- NCI Lecture Series Features Dr. Dennis Slamon
- Free Telephone Workshop Series for Cancer Survivors
- Russian Tobacco Control Forum Draws International Participation
- Lance Armstrong Foundation Improves Its Spanish Web Site
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at email@example.com.